Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
4 |
issn |
1465-542X 1465-5411 |
issueIdentifier |
6 |
pageRange |
390-4 |
publicationName |
Breast cancer research : BCR |
startingPage |
390 |
bibliographicCitation |
Gullick WJ. Update on HER-2 as a target for cancer therapy: alternative strategies for targeting the epidermal growth factor system in cancer. Breast Cancer Res. 2001;3(6):390–4. PMID: 11737891; PMCID: PMC138706. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_484aaab7bfdae47f375cf2c10d0ce32b |
date |
2001-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/11737891 https://doi.org/10.1186/bcr328 https://pubmed.ncbi.nlm.nih.gov/PMC138706 |
isPartOf |
https://portal.issn.org/resource/ISSN/1465-542X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884 https://portal.issn.org/resource/ISSN/1465-5411 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Update on HER-2 as a target for cancer therapy: Alternative strategies for targeting the epidermal growth factor system in cancer |
discusses |
http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0001483 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_966b69495aff24dd4bc4208192414e49 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 |